Commercializing Biomedical Research Through Securitization Techniques
Biomedical innovation has become riskier, more expensive and more difficult to finance with traditional sources such as private and public equity. Here we propose a financial structure in which a large number of biomedical programs at various stages of development are funded by a single entity to su...
| Main Authors: | , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | en_US |
| Published: |
Nature Publishing Group
2013
|
| Online Access: | http://hdl.handle.net/1721.1/78287 https://orcid.org/0000-0003-2944-7773 |